Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN115677771A offers efficient fosfomycin intermediate production with reduced costs and high purity for reliable pharmaceutical supply chains.
Patent CN114085219A details a high-ee synthesis of (1S,6R)-8-benzyl-7,9-dioxo-2,8-diazabicyclo[4.3.0]nonane. This route offers superior yield and purity for reliable pharmaceutical intermediate supply chains.
Patent CN108752217B reveals a green, low-cost route for 2,4-difluorobenzylamine, a key dolutegravir intermediate, offering significant supply chain advantages.
Patent CN1639172A details novel silicon-based reagents for high-ee alcohol synthesis, offering scalable routes for complex pharmaceutical intermediates manufacturing.
Patent CN100588643C details a scalable synthesis for novel disubstituted adamantyl retinoic acids. Offers high purity, simplified processing, and cost-effective API manufacturing solutions.
Novel MoO2 catalyst method for aniline. Green efficient recyclable. Cost reduction in pharma intermediate manufacturing. Reliable supplier for high purity.
Novel synthesis method for 1-(3-methoxypropyl)-4-piperidinamine offering high purity and cost efficiency for pharmaceutical supply chains globally and reliably.
Patent CN104262309A details an iron-catalyzed chromone synthesis. This report analyzes cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability for global buyers.
Patent CN116789664A details a metal-free photocatalytic route for trifluoromethyl benzimidazoloisoquinoline analogues, offering cost-effective and scalable manufacturing solutions.
Patent CN109081810A details a robust 7-step synthesis for Lorlatinib intermediates. Achieves high purity and scalable production for global pharmaceutical supply chains.
Patent CN102757367A details a cost-effective splitting process for DL-benzene ethyl sulfonic acid using L-HPG, offering high purity and supply chain stability for pharmaceutical intermediates.
Patent CN110818576B reveals a novel rare earth catalyzed synthesis of secondary amines. High yield, mild conditions, and cost-effective supply chain solutions for pharma.
Patent CN104725280B reveals ETS-10 catalyzed route for high purity diarylurea intermediates. Delivers cost effective supply chain solutions for global pharmaceutical manufacturing partners.
Patent CN102531987B reveals high-purity chiral intermediate synthesis. Enables cost reduction in pharma manufacturing with scalable supply chain solutions.
Advanced patent CN106478518A enables high-purity Rosuvastatin intermediate production with improved safety and scalability for global supply chains.
Patent CN102408392A details a green aqueous synthesis for 2-(N,N-disubstituted amino)-4-thiazolinone. This method offers high yields, reduced costs, and scalable production for pharma intermediates.
Novel resolution method for levodopa intermediate ensures high purity and cost efficiency. Reliable supply chain partner for pharmaceutical manufacturing needs.
Patent CN1634896A introduces a fixed-bed continuous method for piperazine synthesis, offering high selectivity and lower pressure operation for cost-effective pharmaceutical intermediate manufacturing.
Patent CN106046095B reveals mild Obeticholic acid synthesis. Eliminates LDA cryogenic steps. Enables cost reduction in pharmaceutical intermediates manufacturing.
Novel isoxazoline preparation via Lewis acid catalysis. Mild conditions, high purity, cost-effective manufacturing for pharmaceutical intermediates.